Last updated: July 2, 2025
Sponsor: Abiomed Inc.
Overall Status: Completed
Phase
N/A
Condition
Congestive Heart Failure
Heart Failure
Chest Pain
Treatment
V-A ECMO AUTO Mode algorithm
Clinical Study ID
NCT05759377
2022-R02
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with ongoing or planned ECpella therapy
Exclusion
Exclusion Criteria:
Age < 18 years
Treatment with other than VA ECMO setup
Treatment with Impella CP® heart pump only
Study Design
Total Participants: 46
Treatment Group(s): 1
Primary Treatment: V-A ECMO AUTO Mode algorithm
Phase:
Study Start date:
October 11, 2023
Estimated Completion Date:
June 03, 2025
Study Description
Connect with a study center
Uniklinik RWTH Aachen
Aachen, NRW 52074
GermanySite Not Available
HDZ NRW
Bad Oeynhausen, NRW 32545
GermanySite Not Available
Herzzentrum Dresden GmbH
Dresden, Saxony 01307
GermanySite Not Available
Universitäres Herz- und Gefäßzentrum Hamburg
Hamburg, 20251
GermanySite Not Available
UKGM Universtitätsklinikum Marburg
Marburg,
GermanySite Not Available
Brüderkrankenhaus Trier
Trier,
GermanySite Not Available
Krankenhaus der Barmherzigen Brüder - Herzzentrum Trier
Trier,
GermanySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.